Skip to main content

Table 1 Synopsis of data from previous reviews on severe CMV infections and in immunocompetent patients.

From: Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review

Reference Year of publication

Number of patients

Site involved

Patient demographics

Comorbidity

Antiviral treatment

Outcome

[2]/2007

11

Portal vein thrombosis

55% M/MA 34 y and one infant 4 m

Known thromboembolic risk factors in 64%

ND

Complete thrombus resolution in 73% of patients 2/11 received antiviral treatment

[3]/2005

44

Colitis

61.5% M/61.1(25–71)

18 IM (8 with renal failure, 6 with DM, 2 pregnant), 18 with NM and 10 NC

18.8% in the IM

44% in the NM group

40% in the NC group

MR and SR: 56.3% and 18.8% in the IM, 22% and 33% in the NM group, 10% and 50% in the NC group

[4]/2003

4

Vascular thrombosis and pulmonary embolism

40% M/29–38 y and one neonate

One patient APA, and another FVLH

Ganciclovir one patient, none another ND for 3 patients

Good for personal 2 patients (1 of them received treatment) ND for 3

[5]/2001

15

Colitis

MA 63+/-20 y

ND

34% received AT

31% in the AT group died

36% of those that did not receive AT died**

[6]/2000

19

Meningoencephalitis [16 monophasic (2 of them had multiorgan involvement)] and 3 paroxysmal]

17–78 y

ND

12/16 with monophasic received treatment (8 acyclovir, 3 ganciclovir,1 adenine-arabinoside)

None with paroxysmal received treatment

Monophasic without treatment: 4/5 had CR while 1/5 PR

With treatment: 13/16 CR, 1/16 PR, 2/16 deaths

Paroxysmal: All CR

[7]/1997

27

Hepatitis (15), Nervous system (9), Pneumonitis (2), colitis (1)

44% males, 14–73 y

3 pregnant women

5 ganciclovir, 1 acyclovir, 2 vidarabine, 19 none

1/5 of those who received ganciclovir died, 13/22 of the remaining died

[8]/1985

62

Myocarditis (10), pneumonia (8), encephalitis (7), gastrointestinal infection (8), granulomatous hepatitis (7), haemolytic anaemia (5), icteric hepatitis (3), conjunctivitis (3) severe thrombocytopenia (2), pericarditis (2), meningitis (2), VIII cranial nerve palsy (1), uveitis (1), chorioretinitis (1), rash (2)

ND for the majority 39.8 years old (for patients with granulomatous hepatitis, uveitis, chorioretinitis, gastrointestinal)

ND

ND

All survived except for 3 who died (1 with pericarditis and 2 with gastrointestinal infection)

Relapses in one patient with uveitis and persistence in 1 with chorioretinitis

  1. Abbreviations PVT: portal vein thrombosis, MA: mean age, y: years, m: months, NM: non immune-modulating conditions, NC: no comorbidities, MR: mortality rate, SR: spontaneous remission rate, IBD: inflammatory bowel disease, APA: antiphospholipid antibodies, FVLH: factor V Leiden heterozygous mutation, ND: no data, AT: antiviral treatment, CR: complete recovery, PR: partial recovery, CMV: cytomegalovirus.
  2. **: patients with more severe infections were administered AT.
  3. #:Total number of reports by Karakozis is 38. However 23 patients reviewed by Karakozis and Galiatsatos are the same, and thus deducted from the Karakozis study.